← Open Payments lookup

ROSEMARY BROWN: Open Payments

NPI 1972504231 · REXBURG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,767 in 53 payments from 10 companies in 2025. Trend: 2023 $1,431 · 2024 $1,448 · 2025 $1,767

Food & beverage: $1,656Education: $111
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.10$428
Tris Pharma Inc4$274
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$262
Teva Pharmaceuticals USA, Inc.7$198
Alkermes, Inc.6$174
Otsuka America Pharmaceutical, Inc.7$155
Neurocrine BioSciences, Inc.7$151
ABBVIE INC.4$85
Corium, LLC1$26
Supernus Pharmaceuticals, Inc.1$14

Products named: COBENFY, CAPLYTA, INGREZZA, Dyanavel XR, LYBALVI, REXULTI, VRAYLAR, AUSTEDO XR.

Industry payments across ID — which companies pay providers there.